1 document found, page 1 of 1
Sort by
Issue Date
Upfront lipid-lowering combination therapy in high cardiovascular risk patients...
Banach, Maciej; Surma, Stanisław; Guzik, Tomasz J.; Penson, Peter E.; Blaha, Michael J.; Pinto, Fausto J.; Sperling, Laurence S.Despite three decades of using statin therapy, 20 years of experience with ezetimbe, and availability of innovative non-statin lipid lowering therapies (LLT), there are still about 70% patients over the low-density lipoprotein cholesterol (LDL-C) goal, with every 5th to 6th being over the target from the group of very high and extremely high cardiovascular disease (CVD) risk patients. Adding another even every ...
Date: 2025
|
Origin: Repositório da Universidade de Lisboa